Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Iterum Therapeutics
Fierce Pharma
Iterum initiates wind-down after failure to offload antibiotic
Iterum engaged with two potential suitors for its approved antibiotic Orlynvah, but a deal ultimately couldn't be struck.
Darren Incorvaia
Mar 31, 2026 2:06pm
Iterum's UTI drug faces concerns about antimicrobial resistance
Sep 6, 2024 11:31am
Abbott CEO adds chair to title as White retires—Chutes & Ladders
Dec 17, 2021 9:30am
Former Iterum VP returns as medical lead to test UTI drug again
Dec 13, 2021 11:13am
FDA said no in July, so Iterum will test UTI antibiotic again
Sep 29, 2021 10:05am
From speedy review to standstill: FDA spurns Iterum's antibiotic
Jul 26, 2021 11:11am
